Ateves and Adamas collaborate on new drugs approved by the FDA for Alzheimer's disease December 25, 2014 Source: New Kangjie Recently, the FDA approved the compound new drug Namzaric developed by Ateves in collaboration with Adamas for moderate to severe Alzheimer's senile dementia. Namzaric is a once-a-day oral capsule that can be opened to spread the contents onto food to facilitate patients who may have difficulty swallowing. Global generics giant Actavis and partner Adamas Pharmaceuticals recently announced that the new drug Namzaric has been approved by the FDA for moderate to severe Alzheimer's treatment with memantine hydrochloride and donepezil hydrochloride. Treatment of Alzheimer's type dementia. Ateves plans to bring Namzaric to market in 2015. Namzaric is a once-a-day oral capsule consisting of a fixed dose of memantine and doneabine (Emantine ER/donepezil) for the current administration of memantine (10 mg twice daily; or 28 mg sustained release tablets once daily) And patients with donepezil (10 mg). In addition, the capsule can be opened to sprinkle the contents onto the food to facilitate patients who may have difficulty swallowing. The combination of memantine and donepezil is an effective treatment for patients with moderate to severe Alzheimer's senile dementia. Namzaric (sustained release of memantine ER / donepezil) helps to reduce the burden of daily medication for patients and improve patient compliance and compliance (compliance). Namzaric includes 2 doses, 28mg/10mg and 14mg/10mg, which can be used in patients with severe renal impairment. Currently, memantine ER capsules are marketed under the brand name NAMENDA XR and are suitable for the treatment of moderate to severe Alzheimer's type dementia. The donepezil brand is called ARICEPT and is indicated for the treatment of mild to severe Alzheimer's type dementia. In February of this year, Ateves spent $25 billion to acquire Forest Lab, which included Namzaric and Alzheimer's drug Namenda and some new drugs such as anti-depressant Viibryd. Heparin was added in the green head of the heparin anticoagulant tube. Heparin has a direct antithrombin effect and can prolong the coagulation time of the specimen. It is used in emergency and most biochemical tests, such as liver function, renal function, blood lipids, and blood glucose. It is suitable for erythrocyte fragility test, blood gas analysis, hematocrit test, erythrocyte sedimentation rate and common biochemical test. It is not suitable for hemagglutination test. Excessive amounts of heparin cause aggregation of leukocytes and cannot be used for leukocyte counting. Because it can make the background of blood stain pale blue, it is also not suitable for leukocyte classification. It can be used for hemorheological use, the sample type is plasma, and immediately after blood collection, it is reversed and mixed 5-8 times, and the upper plasma is taken for use. lithium heparin tube,sodium heparin tube,heparin blood collection tubes,green top vacutainer Ningbo Siny Medical Technology Co., Ltd , https://www.sinymedical.com
We are manufacturers and suppliers wholesale Heparin Tube. Sizes range from 2ml to 10ml. In addition, we offer customizable services. Siny Medical can meet your needs. If you are in need of Heparin Tube manufacturers and suppliers, please contact us.
Ateves and Adamas collaborate on new drugs approved by the FDA for Alzheimer's disease